Jasmine A. Donaldson
London, ENG WC1N3BG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion.
Journal: NAR molecular medicine
Published: February 25, 2026
Huntington disease: somatic expansion, pathobiology and therapeutics.
Journal: Nature reviews. Neurology
Published: October 03, 2025
Antisense oligonucleotide-mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington's disease iPSC-derived striatal neurons.
Journal: Science translational medicine
Published: February 12, 2025
Olympic distance duathlon and cardiac performance in highly-trained triathletes.
Journal: Physiological reports
Published: July 09, 2024
Mutant huntingtin confers cell-autonomous phenotypes on Huntington's disease iPSC-derived microglia.
Mutant huntingtin confers cell-autonomous phenotypes on Huntington's disease iPSC-derived microglia.
Journal: Scientific reports
Published: August 28, 2023
Genetic modifiers of repeat expansion disorders.
Journal: Emerging topics in life sciences
Published: May 19, 2023
Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset.
Journal: Nature neuroscience
Published: May 06, 2021
What is the Pathogenic CAG Expansion Length in Huntington's Disease?
Journal: Journal of Huntington's disease
Published: February 13, 2021
Left Ventricular Function and Cardiac Biomarker Release-The Influence of Exercise Intensity, Duration and Mode: A Systematic Review and Meta-Analysis.
Journal: Sports medicine (Auckland, N.Z.)
Published: June 20, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026